Vincent Mooser, MD, is a Professor in the Department of Human Genetics at McGill University's Faculty of Medicine and Health Sciences and an Associate Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC). He is a key member of the Cardiovascular Health Across the Lifespan Program at RI-MUHC, focusing on translational genomic research in cardiovascular and metabolic disorders. Dr. Mooser's research centers on cardiovascular genetics, genomics, and precision medicine, with emphasis on pharmacogenetics, obesity-related diseases, and population-specific genetic variations. His work leverages multi-ancestry cohorts and integrative 'omics' approaches to identify causal pathways and therapeutic targets, particularly in coronary artery disease and metabolic complications. He has pioneered research on genetic determinants of drug responses and disease susceptibility across diverse populations. Analysis of his recent publications (2024-2025) reveals a dominant focus on multi-ancestry Mendelian randomization, proteogenomics, and biobank-driven studies. Key trends include the identification of actionable mediators like endotrophin in obesity-related cardiovascular disease, development of population-specific genomic tools for French-Canadian cohorts, and investigations into long COVID genetics. His work consistently bridges fundamental genomics with clinical applications through initiatives like the Biobanque québécoise de la COVID-19 (BQC19). Dr. Mooser co-leads the BQC19 biobank initiative and contributes to the Cardiovascular Health Across the Lifespan Program at RI-MUHC, utilizing large-scale genomic datasets and collaborative frameworks to advance precision medicine in cardiovascular health.




